|
FBXL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
6.30684393598813E-12 |
| Normal-vs-Stage3 |
1.01859631840284E-11 |
| Normal-vs-Stage4 |
2.75589551179678E-11 |
| Stage1-vs-Stage2 |
9.804800E-01 |
| Stage1-vs-Stage3 |
9.250400E-01 |
| Stage1-vs-Stage4 |
4.943400E-01 |
| Stage2-vs-Stage3 |
9.220000E-01 |
| Stage2-vs-Stage4 |
4.558400E-01 |
| Stage3-vs-Stage4 |
5.290800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.63524749297039E-12 |
| Normal-vs-Asian |
2.7172000205411E-09 |
| Caucasian-vs-AfricanAmerican |
1.131370E-01 |
| Caucasian-vs-Asian |
5.127200E-01 |
| AfricanAmerican-vs-Asian |
2.852200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.4432899320127E-15 |
| Male-vs-Female |
1.012620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.11974882091681E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
4.64699945190716E-10 |
| Normal_Weight-vs-Extreme_Weight |
5.928400E-01 |
| Normal_Weight-vs-Obese |
7.732800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.189400E-01 |
| Extreme_Weight-vs-Obese |
2.546400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.689200E-01 |
| Obese-vs-Extreme_Obese |
3.307800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.14872564185953E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.500100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.873370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.701600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.019500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.312010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.761600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
1.84963155902551E-12 |
| Normal-VS-Unclassified PRCC |
5.61929947018314E-10 |
| Type1 PRCC-VS-Type2 PRCC |
8.205800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.151960E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.022600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.727900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.499570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.961800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.06303854607859E-12 |
| Normal-vs-N2 |
2.62889998658977E-09 |
| N0-vs-N1 |
3.210800E-01 |
| N0-vs-N2 |
1.139430E-01 |
| N1-vs-N2 |
1.283930E-03 |
|
|
